CNA landscape of HER2-negative breast cancer during administration of taxane-containing schemes of neoadjuvant chemotherapy
Introduction. Evaluation of when and how to include taxanes in preoperative chemotherapy is becoming more important in the era when molecular and genetic approaches allow to develop biologically targeted therapeutic medications and select patients who can benefit from certain cytotoxic agents.Aim. T...
Saved in:
Main Authors: | M. K. Ibragimova, E. A. Kravtsova, M. M. Tsyganov, N. V. Litviakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2025-04-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01) -
Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
by: M. K. Ibragimova, et al.
Published: (2020-10-01) -
The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01) -
TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01) -
MicroRNA-dependent mechanisms of taxane resistance in breast cancer
by: V. S. Apollonova, et al.
Published: (2022-12-01)